Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ramipril for intermittent claudication
2009-016600-23Phase 4Terminated
- Sponsor
- Hull University Teaching Hospitals
- Start
- Jun 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in intermittent claudication (IC) and arteriosclerosis obliterans comparing Ramipril with Placebo (2 arms). Primary endpoint: Maximum walking distance. Started Jun 2010; status: terminated.
02
Drugs
ramipril
03
Conditions
intermittent claudication (IC)arteriosclerosis obliterans
Beyond the preview
Go deeper on 2009-016600-23.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-016600-23.